Cite

HARVARD Citation

    Chen, W. et al. (2018). In vivo hepatocellular expression of interleukin-22 using penetratin-based hybrid nanoparticles as potential anti-hepatitis therapeutics. Biomaterials. pp. 66-80. [Online]. 
  
Back to record